Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Buckner

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Oncology|December 13, 2002
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanomaSvetomir Markovic, Vera J Suman, Robert J Dalton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
JAMA|July 27, 2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical TrialPaul D Brown, Kurt Jaeckle, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group studyEvanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Journal of Neuro-Oncology|January 12, 2010
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBMKurt A Jaeckle, Karla V Ballman, Caterina Giannini, et al.
Neuro-Oncology|October 11, 2017
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical dataJann N Sarkaria, Leland S Hu, Ian F Parney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Oncology|December 13, 2002
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanomaSvetomir Markovic, Vera J Suman, Robert J Dalton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
JAMA|July 27, 2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical TrialPaul D Brown, Kurt Jaeckle, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group studyEvanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Journal of Neuro-Oncology|January 12, 2010
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBMKurt A Jaeckle, Karla V Ballman, Caterina Giannini, et al.
Neuro-Oncology|October 11, 2017
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical dataJann N Sarkaria, Leland S Hu, Ian F Parney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Pageof 14